As the number of lawsuits filed against Merck over the hair loss drug Propecia continues to increase, two studies have been released that give weight to plaintiff’s claims.
A study published in the July 12, Journal of Sexual Medicine by Dr. Michael Irwig from George Washington University finds that of the 54 young, healthy Propecia users involved in the study, 96 percent were found to have sexual dysfunction that continued for more than 12 months after stopping the drug.
This month, the Journal of Clinical Psychiatry published a second study by Dr. Irwig that found of 61 healthy, young Propecia users, 36 percent had severe depression symptoms while 44 percent had suicidal thoughts.
As more of these types of published, Propecia users scramble for answers, and continue to file lawsuits against Merck alleging they have “experienced persistent sexual side effects following cessation of the treatment with Propecia and/or Proscar.” Proscar and Propecia are the brand names for finasteride. Proscar is used in the treatment of prostate enlargement, the Examiner explains.
At the end of the first quarter, Merck reported 80 Propecia/Proscar lawsuits, with 175 plaintiffs, however, by the end of the second quarter the number of lawsuits had jumped to 200 with 325 plaintiffs.